ICYMI: Molecular Therapy has a new editor-in-chief! Joseph C. Glorioso, PhD (@UPMCnews) is a trailblazing #genetherapy researcher and founding member of ASGCT. He will assume the role on January 1, 2025.

Learn more about him on our blog! bit.ly/4bC0EvY

Congratulations!!

We hope you're all feeling refreshed and recovered from #ASGCT2024 last week!

If you attended in person or virtually and there's anything you'd like to rewatch, do so through June 21 on the virtual meeting platform! bit.ly/3UXetiS

Wow, what a week at #ASGCT2024 !

We hope you learned from the science, met fellow members, and saw some great presentations this week!

THANK YOU, everyone! See you in New Orleans next year!

Proud to be mentor for my visionary student. Twenty years back went to Canada to do genetics . Now Prof of Genetics and rare diseases in Queens University ⁦ASGCT⁩

Good morning #ASGCT2024 attendees! Today, hear from our final oral abstract presenters and symposia speakers to close out the 27th Annual Meeting. All attendees will have access to sessions on demand for 30 days on the meeting platform + app.

One of the best aspects of #ASGCT2024 : reuniting with former lab members and collaborators.
With Gregory Newby (now a professor at Johns Hopkins), Xiao Wang, Samagya Banskota (now a professor at Boston University), Meirui An, Mandana Arbab (now a professor at Harvard…

Dr. Jenny Greig, Executive Director of Research at Penn's Gene Therapy Program, will present at the ASGCT conference this morning! Dr. Greig’s presentation, 'AAV Vector Integration,' is scheduled to begin at 8:52 a.m. during the Scientific Symposium. #ASGCT2024 📸: ASGT

Many developers know they need a #companion diagnostic for #AAV products, but aren’t sure where to start. The Companion Diagnostics for AAV-based Gene Therapies session will answer questions about regulatory requirements + challenges #ASGCTadvocacy bit.ly/3HFSrdi

Thanks a lot, Kevin Davies for this nice article on the #ASGCT2024 gene editing & delivery workshop that Holly Rees and I co-organized with the help of Dani Gale ASGCT. And thanks again to all the fantastic speakers on Tuesday🧬

PPMD is proud to share some exciting news: our very own President and CEO, Pat Furlong, has been named the 2024 recipient of the prestigious Sonia Skarlatos Public Service Award by ASGCT. Congratulations, Pat, on this well-deserved honor! parentprojectmd.org/ppmds-pat-furl…

Get ready to meet our #MolecularTherapy editors at noon!

Stop by ASGCT Central (booth 815) to chat with editors from our family of high-impact journals. #ASGCT2024

Curious about projects funded by ARPA-H + other #translational science agencies? #ASGCT2024 will bring together leaders of organizations that support translational science to answer your questions in a fireside chat, with extended Q&A #ASGCTadvocacy bit.ly/3HFSrdi

ASGCT is proud to partner with Pfizer Inc. on a new competitive grant opportunity supporting independent medical education on #genetherapies and gene-modified therapies for #rarediseases ! Apply through July 1: bit.ly/4dIWTXs.

Great discussion today with speakers from U.S. FDA, 独立行政法人 医薬品医療機器総合機構(PMDA), and @ANVISA_Official on #regulatory convergence. Presenters shared their joint priorities and the unique challenges of operating on a global regulatory scale #ASGCT2024 #ASGCTadvocacy

Coming up soon at #ASGCT2024 : Hear from Drs. Beverly Davidson (Children's Hospital) + Philip Gregory (@Regeneron) during today's George Stamatoyannopoulos Memorial Lecture and from David R. Liu during the Outstanding Achievement Award Presentation! bit.ly/3HFSrdi

Check out the Exhibit Hall and view the first day of abstract posters until 7 p.m. ET tonight!

What have you enjoyed on Day 2 of #ASGCT2024 ? Remember that you can catch up on sessions on demand on the virtual platform for 30 days. bit.ly/3HFSrdi

Happening now in room 318-320: David Cheng (Arbor Biotechnologies) kicking off Communications Committee symposium on generative AI in #CGT ! #ASGCT2024

TODAY at #ASGCT2024 - Join Peter Marks (FDA Biologics) in a fireside chat moderated by Kristin Van Goor (@TakedaPharma) this morning! They'll navigate the pathways from IND to BLA - a must-watch for understanding the #regulatory landscape! #ASGCTadvocacy bit.ly/3HFSrdi

Congratulations to Kathy High, MD, the 2024 recipient of the ASGCT Founders Award! #ASGCT2024